En esta página
01TNXP precio
02Instantánea
03Gráfico
04Divisiones de acciones
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
26Mis Métricas
TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 10, 2026
$8,91
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$8,69mínimo 52 semanas
$25,40máximo 52 semanas
Capitalización Bursátil (MRQ)
$150M
P/E (TTM)
-0.7
BPA (TTM)
$-13.24
Ingresos (TTM)
$29M
tus insignias
Rango 52S
$9–$25
Calificación del Analista
BUY
Precio Objetivo
$44
P/E
-0.7
ROE
-81.8%
Margen de Beneficio Neto
-548.6%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
TNXP Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$8.91
Capitalización Bursátil (MRQ)
$150M
P/E (TTM)
-0.7
BPA (TTM)
$-13.24
Ingresos (TTM)
$29M
ROE (TTM)
-81.8%
Rango 52S
$9–$25
TNXP Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 5 de febrero de 2025 | 1-for-100 | Inversa |
| 10 de junio de 2024 | 1-for-32 | Inversa |
| 10 de mayo de 2023 | 1-for-6 | Inversa |
| 17 de mayo de 2022 | 1-for-32 | Inversa |
| 1 de noviembre de 2019 | 1-for-10 | Inversa |
| 28 de noviembre de 2018 | 1-for-10 | Inversa |
| 17 de marzo de 2017 | 1-for-10 | Inversa |
| 1 de mayo de 2013 | 1-for-20 | Inversa |
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$13M2023-12-31 → 2025-12-31
BPA$-14.572021-12-31 → 2025-12-31
Flujo de caja libre$-103M2017-12-31 → 2025-12-31
Margen neto-548.6%2023-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | TNXP | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -0.7promedio 5A ≈-5767.1 | ≈-5767.1 | · | · | |
| P/S (TTM) | 5.1promedio 5A ≈3229.3 | ≈3229.3 | 6.2 | Sobrevalorado | |
| P/C (MRQ) | 0.7promedio 5A ≈105269.0 | ≈105269.0 | 3.2 | Infravalorado | |
| Precio / FCF (TTM) | -0.9promedio 5A ≈-207215.1 | ≈-207215.1 | · | · | |
| Precio / Flujo de Caja (TTM) | -1.0promedio 5A ≈-304010.4 | ≈-304010.4 | · | · | |
| Precio / Valor Contable Tangible (MRQ) | 0.7promedio 5A ≈105342.8 | ≈105342.8 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | TNXP | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | -568.4%promedio 5A ≈-1279.1% | ≈-1279.1% | -226.0% | Débil | |
| Margen EBITDA (TTM) | -561.1%promedio 5A ≈-1244.5% | ≈-1244.5% | -171.3% | Débil | |
| Margen de Beneficio Neto (TTM) | -548.6%promedio 5A ≈-1245.4% | ≈-1245.4% | -259.7% | En línea | |
| ROA (TTM) | -72.3%promedio 5A ≈-60.3% | ≈-60.3% | -37.1% | Débil | |
| ROE (TTM) | -81.8%promedio 5A ≈-75.8% | ≈-75.8% | -54.4% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | TNXP | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 6.6promedio 5A ≈6.5 | ≈6.5 | 7.5 | Baja liquidez | |
| Quick Ratio (Ratio Rápido) | 6.9promedio 5A ≈5.7 | ≈5.7 | 7.1 | Baja liquidez |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | TNXP | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | 29.8% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | TNXP | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.1promedio 5A ≈0.1 | ≈0.1 | 0.1 | Débil | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 2.6 | · | 3.4 | Débil | |
| Revenue / Employee (Ingresos / Empleado) | ≈$92.3K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-5.2%
Próximo informe
Nov 09, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 10, 2026 | $-2.44 | $-2.75 | 11.3% |
| 31 de marzo de 2026 | May 11, 2026 | $-2.93 | $-2.48 | -18.0% |
| 31 de diciembre de 2025 | $-3.98 | $-3.25 | -22.3% | |
| 30 de septiembre de 2025 | $-3.59 | $-3.66 | 1.8% | |
| 30 de junio de 2025 | $-3.86 | $-3.28 | -17.7% | |
| 31 de marzo de 2025 | $-2.84 | $-3.29 | 13.8% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $13M | $10M | $8M | |
| Cost of Revenue | $7M | $8M | $5M | |
| R&D Expense | $44M | $40M | $87M | |
| SG&A Expense | $88M | $40M | $35M | |
| Operating Expenses | $139M | $147M | $126M | |
| Operating Income | $-126M | $-137M | $-118M | |
| Interest Income | $4M | $22.0K | $2M | |
| Other Non-op | $-3M | $-867.0K | $2M | |
| Net Income | $-124M | $-130M | $-117M | |
| EPS (Basic) | $-14.57 | $-176.60 | $-14720.25 | |
| EPS (Diluted) | $-14.57 | $-176.60 | $-14720.25 | |
| Shares (Basic) | 8,511,318 | 736,339 | 7,925 | |
| Shares (Diluted) | 8,511,318 | 736,339 | 7,925 | |
| EBITDA | $-124M | $-133M | $-114M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $208M | $99M | $25M | |
| Receivables | $6M | $4M | · | |
| Inventory | · | $8M | $14M | |
| Prepaid Expense | $9M | $8M | $9M | |
| Other Current Assets | · | · | $2M | |
| Current Assets | $229M | $119M | $48M | |
| PP&E (Net) | $44M | $42M | $94M | |
| PP&E (Gross) | $50M | $46M | $99M | |
| Accum. Depreciation | $6M | $4M | $5M | |
| Goodwill | · | · | $965.0K | |
| Intangibles | $120.0K | $120.0K | $10M | |
| Other Non-current Assets | $2M | $951.0K | $1M | |
| Total Assets | $277M | $163M | $154M | |
| Accounts Payable | $8M | $5M | $4M | |
| Current Liabilities | $31M | $18M | $19M | |
| Capital Leases | $1M | $358.0K | $632.0K | |
| Total Liabilities | $32M | $23M | $49M | |
| Long-term Debt | · | $9M | $11M | |
| Total Debt | · | $7M | $9M | |
| Common Stock | $13.0K | $4.0K | · | |
| Retained Earnings | $-855M | $-731M | $-601M | |
| AOCI | $-289.0K | $-255.0K | $-232.0K | |
| Stockholders' Equity | $245M | $140M | $106M | |
| Liabilities + Equity | $277M | $163M | $154M | |
| Shares Outstanding | 12,788,069 | 4,385,929 | 20,926 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $2M | $3M | $4M | |
| Stock-based Comp | $6M | $5M | $9M | |
| Amort. of Intangibles | $0 | $500.0K | $477.0K | |
| Other Non-cash | $16M | $61M | $1M | |
| Operating Cash Flow | $-100M | $-61M | $-102M | |
| CapEx | $3M | $120.0K | $8M | |
| Investing Cash Flow | $-5M | $-120.0K | $-29M | |
| Net Debt Issued | $-10M | $-2M | · | |
| Stock Issued | $238M | $140M | $19M | |
| Stock Repurchased | $14M | · | $14M | |
| Net Stock Activity | $224M | $140M | $5M | |
| Financing Cash Flow | $215M | $135M | $37M | |
| Net Change in Cash | $110M | $74M | $-95M | |
| Free Cash Flow | $-103M | $-61M | $-110M |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -959.1% | -1354.3% | -1523.9% | |
| Net Margin | -946.2% | -1288.2% | -1501.8% | |
| EBITDA Margin | -944.4% | -1320.4% | -1468.7% | |
| ROA | -56.4% | -82.0% | -61.4% | |
| ROE | -60.0% | -121.7% | -103.1% |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 7.4 | 6.5 | 2.5 | |
| Quick Ratio | 6.9 | 5.6 | 1.3 | |
| Debt / Equity | · | 0.1 | 0.1 | |
| LT Debt / Equity | · | 0.0 | 0.1 |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.0 | |
| Inventory Turnover | · | 0.7 | 0.7 | |
| Receivables Turnover | 2.6 | 5.5 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Book Value / Share | $19.17 | $31.82 | $1.80 | |
| Revenue / Share | $1.54 | $13.71 | $0.46 | |
| Cash Flow / Share | $-11.73 | $-82.74 | $-5.99 | |
| Cash / Share | $16.24 | $22.52 | $0.43 | |
| EPS (TTM) | $-14.57 | $-176.60 | $-14720.25 |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 29.8% | 29.9% | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $13M | $10M | $8M | |
| Net Income TTM | $-124M | $-130M | $-117M | |
| Market Cap | $200M | $145M | $75.03B | |
| Enterprise Value | · | $53M | $75.01B | |
| P/E | -1.1 | -0.2 | -0.1 | |
| P/S | 15.2 | 14.3 | 9658.4 | |
| P/B | 0.8 | 1.0 | 711.0 | |
| P / Tangible Book | 0.8 | 1.0 | 791.3 | |
| P / Cash Flow | -2.0 | -2.4 | -735.5 | |
| P / FCF | -1.9 | -2.4 | -682.7 | |
| EV / EBITDA | · | -0.4 | -657.5 | |
| EV / FCF | · | -0.9 | -682.5 | |
| EV / Revenue | · | 5.3 | 9656.4 | |
| Earnings Yield | -93.3% | -535.1% | -1150.0% |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14M | $7M | $5M | $3M | $2M | $2M | $3M | $3M | $2M | $2M | $4M | $4M | |
| Cost of Revenue | $703.0K | $2M | $1M | $1M | $3M | $943.0K | $1M | $2M | $3M | $2M | $2M | $2M | |
| R&D Expense | $19M | $18M | $17M | $9M | $11M | $7M | $8M | $9M | $10M | $13M | $17M | $21M | |
| SG&A Expense | $36M | $29M | $36M | $26M | $16M | $10M | $16M | $8M | $8M | $9M | $12M | $9M | |
| Operating Expenses | $56M | $48M | $54M | $36M | $30M | $18M | $25M | $18M | $80M | $24M | $31M | $32M | |
| Operating Income | $-43M | $-42M | $-48M | $-33M | $-28M | $-16M | $-22M | $-16M | $-77M | $-21M | $-27M | $-28M | |
| Interest Income | · | $1M | $1M | $1M | · | $394.0K | $1.0K | $18.0K | · | · | · | $172.0K | |
| Other Non-op | $-49.0K | $-3.0K | $-578.0K | $-1M | $-2M | · | $376.0K | $-44.0K | $-606.0K | $-593.0K | $7.0K | $172.0K | |
| Net Income | $-41M | $-40M | $-47M | $-32M | $-28M | $-17M | $-22M | $-14M | $-79M | $-15M | $-27M | $-28M | |
| EPS (Basic) | $-2.44 | $-2.93 | $-4.28 | $-3.59 | $-3.86 | $-2.84 | $2302.65 | $-22.68 | $-1920.85 | $-535.72 | $-14629.18 | $-38.63 | |
| EPS (Diluted) | $-2.44 | $-2.93 | $-4.28 | $-3.59 | $-3.86 | $-2.84 | $2302.65 | $-22.68 | $-1920.85 | $-535.72 | $-14629.18 | $-38.63 | |
| Shares (Basic) | 16,635,254 | 13,707,104 | · | 8,922,792 | 7,327,257 | 5,927,231 | · | 626,669 | 41,011 | 27,886 | · | 724,190 | |
| Shares (Diluted) | 16,635,254 | 13,707,104 | · | 8,922,792 | 7,327,257 | 5,927,231 | · | 626,669 | 41,011 | 27,886 | · | 724,190 | |
| EBITDA | $-43M | $-41M | · | $-33M | $-28M | $-16M | · | $-16M | $-77M | $-20M | · | $-28M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $176M | $185M | $208M | $190M | $125M | $132M | $99M | $28M | $4M | $7M | $25M | $7M | |
| Receivables | $12M | $9M | $6M | $3M | $2M | $3M | $4M | $4M | $3M | · | · | $2M | |
| Inventory | · | · | · | · | · | · | · | $8M | $9M | $12M | $14M | $13M | |
| Prepaid Expense | $11M | $9M | $9M | $9M | $10M | $6M | $8M | $10M | $8M | $11M | $9M | $10M | |
| Other Current Assets | · | · | · | · | · | · | · | $2M | · | · | · | · | |
| Current Assets | $203M | $207M | $229M | $208M | $144M | $150M | $119M | $51M | $25M | $30M | $48M | $31M | |
| PP&E (Net) | $45M | $45M | $44M | $43M | $42M | $42M | $42M | $43M | $43M | $93M | $94M | $95M | |
| PP&E (Gross) | $52M | $51M | $50M | $48M | $47M | $46M | $46M | $46M | $46M | $99M | $99M | $99M | |
| Accum. Depreciation | $7M | $7M | $6M | $6M | $5M | $5M | $4M | $4M | $3M | $6M | $5M | $4M | |
| Goodwill | · | · | · | · | · | · | · | · | · | $965.0K | $965.0K | $965.0K | |
| Intangibles | $120.0K | $120.0K | $120.0K | $120.0K | $120.0K | $120.0K | $120.0K | $120.0K | $120.0K | $10M | $10M | $10M | |
| Other Non-current Assets | $5M | $4M | $2M | $1M | $931.0K | $910.0K | $951.0K | $951.0K | $961.0K | $960.0K | $1M | $1M | |
| Total Assets | $254M | $258M | $277M | $252M | $187M | $193M | $163M | $95M | $70M | $135M | $154M | $139M | |
| Accounts Payable | $9M | $10M | $8M | $9M | $8M | $4M | $5M | $4M | $10M | $7M | $4M | $8M | |
| Current Liabilities | $31M | $30M | $31M | $21M | $19M | $12M | $18M | $15M | $22M | $20M | $19M | $18M | |
| Capital Leases | $1M | $1M | $1M | $266.0K | $297.0K | $328.0K | $358.0K | $425.0K | $493.0K | $563.0K | $632.0K | $716.0K | |
| Total Liabilities | $32M | $31M | $32M | $21M | $19M | $12M | $23M | $21M | $28M | $27M | $49M | $18M | |
| Long-term Debt | · | · | · | · | · | · | $9M | $9M | $10M | $11M | $11M | · | |
| Total Debt | · | · | · | · | · | · | · | $8M | $8M | $9M | · | · | |
| Common Stock | $17.0K | $14.0K | $13.0K | $10.0K | $8.0K | $7.0K | $4.0K | $156.0K | $10.0K | $74.0K | · | $18.0K | |
| Retained Earnings | $-935M | $-895M | $-855M | $-808M | $-776M | $-748M | $-731M | $-709M | $-694M | $-616M | $-601M | $-573M | |
| AOCI | $-348.0K | $-283.0K | $-289.0K | $-274.0K | $-270.0K | $-266.0K | $-255.0K | $-250.0K | $-243.0K | $-240.0K | $-232.0K | $-220.0K | |
| Stockholders' Equity | $222M | $227M | $245M | $231M | $168M | $180M | $140M | $74M | $42M | $108M | $106M | $121M | |
| Liabilities + Equity | $254M | $258M | $277M | $252M | $187M | $193M | $163M | $95M | $70M | $135M | $154M | $139M | |
| Shares Outstanding | 16,792,317 | 14,205,401 | 12,788,069 | 10,168,204 | 7,546,276 | 6,877,816 | 4,385,929 | 155,631,049 | 9,832,587 | 73,724,196 | 20,926 | 17,762,341 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $619.0K | $555.0K | $488.0K | $461.0K | $483.0K | $493.0K | $496.0K | $510.0K | $1M | $1M | $1M | $1M | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $1M | $882.0K | $894.0K | $1M | $1M | $2M | $2M | $2M | |
| Amort. of Intangibles | · | $0 | $0 | $0 | · | $0 | $100.0K | $0 | $200.0K | $200.0K | · | $238.0K | |
| Other Non-cash | · | $-5M | · | · | · | $-1M | · | · | · | $-6M | · | · | |
| Operating Cash Flow | $-42M | $-42M | $-40M | $-29M | $-15M | $-17M | $-15M | $-19M | $-10M | $-18M | $-22M | $-23M | |
| CapEx | $587.0K | $2M | $2M | $962.0K | $527.0K | $6.0K | $3.0K | $9.0K | $0 | $108.0K | $438.0K | $2M | |
| Investing Cash Flow | $-587.0K | $-2M | $-1M | $-962.0K | $-3M | $-6.0K | $-3.0K | $-9.0K | $0 | $-108.0K | $-431.0K | $-821.0K | |
| Net Debt Issued | · | · | · | · | · | $-10M | · | · | · | $-235.0K | · | · | |
| Stock Issued | $33M | $20M | $67M | $95M | $14M | $62M | $86M | $44M | · | · | $9M | $6M | |
| Stock Repurchased | · | · | $8M | $0 | $3M | $3M | · | · | · | · | $0 | $0 | |
| Net Stock Activity | · | $20M | · | · | $-3M | $59M | · | · | · | · | · | · | |
| Financing Cash Flow | $34M | $20M | $59M | $95M | $11M | $50M | $85M | $43M | $7M | $-212.0K | $41M | $6M | |
| Net Change in Cash | $-9M | $-24M | $18M | $65M | $-6M | $33M | $71M | $24M | $-3M | $-18M | $18M | $-18M | |
| Free Cash Flow | · | $-44M | · | · | · | $-17M | · | · | · | $-18M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -314.1% | -603.9% | · | -1005.1% | -1416.2% | -660.9% | · | -551.2% | -3501.6% | -860.2% | · | -705.6% | |
| Net Margin | -299.4% | -584.4% | · | -972.9% | -1415.0% | -692.8% | · | -503.7% | -3567.8% | -601.9% | · | -701.3% | |
| EBITDA Margin | -314.1% | -595.8% | · | -1005.1% | -1416.2% | -640.6% | · | -551.2% | -3501.6% | -811.5% | · | -705.6% | |
| ROA | -18.4% | -17.8% | · | -18.4% | -21.9% | -10.2% | · | -12.1% | -68.5% | -9.5% | · | -14.6% | |
| ROE | -20.8% | -19.7% | · | -21.0% | -26.9% | -11.7% | · | -14.6% | -86.3% | -10.9% | · | -16.0% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.6 | 7.0 | · | 9.9 | 7.5 | 12.3 | · | 3.3 | 1.1 | 1.5 | · | 1.8 | |
| Quick Ratio | 6.1 | 6.6 | · | 9.2 | 6.7 | 11.1 | · | 2.1 | 0.3 | 0.3 | · | 0.5 | |
| Debt / Equity | · | · | · | · | · | · | · | 0.1 | 0.2 | 0.1 | · | · | |
| LT Debt / Equity | · | · | · | · | · | · | · | 0.1 | 0.1 | 0.1 | · | · |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | · | 0.1 | 0.3 | 0.3 | · | 0.4 | |
| Receivables Turnover | 1.9 | 1.1 | · | 0.9 | 0.7 | 1.5 | · | 1.0 | 1.3 | · | · | 5.1 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $13.24 | $15.99 | · | $22.73 | $22.26 | $26.23 | · | $0.48 | $4.28 | $1.47 | · | $6.80 | |
| Revenue / Share | $0.81 | $0.50 | · | $0.37 | $0.27 | $0.41 | · | $0.05 | $0.54 | $0.03 | · | $0.26 | |
| Cash Flow / Share | · | $-3.09 | · | · | · | $-2.80 | · | · | · | $-0.22 | · | · | |
| Cash / Share | $10.49 | $13.06 | · | $18.69 | $16.61 | $19.15 | · | $0.18 | $0.42 | $0.10 | · | $0.39 | |
| EPS (TTM) | $-13.24 | $-14.66 | · | $2292.36 | $2273.27 | $356.28 | · | $-17108.43 | $-17124.38 | $-15252.76 | · | $-97.59 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $29M | $18M | · | $10M | $10M | $10M | · | $11M | $12M | · | · | · | |
| Net Income TTM | $-160M | $-147M | · | $-99M | $-81M | $-132M | · | $-135M | $-149M | $-99M | · | $-121M | |
| Market Cap | $214M | $195M | · | $246M | $272M | $123M | · | $2.33B | $688M | $44.82B | · | $31.26B | |
| Enterprise Value | · | · | · | · | · | · | · | $2.31B | $693M | $44.83B | · | · | |
| P/E | -1.0 | -0.9 | · | 0.0 | 0.0 | 0.1 | · | -0.0 | -0.0 | -0.0 | · | -18.0 | |
| P/S | 7.4 | 11.1 | · | 23.9 | 27.6 | 12.2 | · | 206.8 | 55.2 | · | · | · | |
| P/B | 1.0 | 0.9 | · | 1.1 | 1.6 | 0.7 | · | 31.5 | 16.3 | 414.5 | · | 258.7 | |
| P / Tangible Book | 1.0 | 0.9 | · | 1.1 | 1.6 | 0.7 | · | 31.5 | 16.4 | 458.9 | · | 284.5 | |
| P / Cash Flow | · | -4.6 | · | · | · | -7.4 | · | · | · | -2550.5 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | 205.0 | 55.6 | · | · | · | |
| Earnings Yield | -103.8% | -106.6% | · | 9488.2% | 6318.1% | 1992.6% | · | -114056.2% | -24463.4% | -2508.7% | · | -5.5% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $13M | $10M | $8M | · | · |
| Margen Operativo % | -959.1% | -1354.3% | -1523.9% | · | · |
| Beneficio neto | $-124M | $-130M | $-117M | $-110M | $-92M |
| EPS Diluido | $-14.57 | $-176.60 | $-14720.25 | $-20.01 | $-8.10 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Deuda / Patrimonio | · | 0.1 | 0.1 | · | · |
| Ratio corriente | 7.4 | 6.5 | 2.5 | 7.2 | 8.7 |
| Ratio Rápido | 6.9 | 5.6 | 1.3 | 6.6 | 8.2 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-103M | $-61M | $-110M | $-146M | $-111M |
Propietarios institucionales (13F) 111 declarantes · $135.6M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
111
Valor en tenencia
$135.6M
Nuevas posiciones
29
Posiciones cerradas
5
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 29 (+8 vs trimestre anterior) | 5 (-1 vs trimestre anterior) | 54 (+19 vs trimestre anterior) | 10 (-6 vs trimestre anterior) | +4.7M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| BlackRock, Inc. | $17 839 002 | 1 398 041 | 13,15% | Acciones |
| Point72 Asset Management, L.P. | $14 887 756 | 1 166 752 | 10,98% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $12 338 052 | 966 932 | 9,10% | Acciones |
| AQR CAPITAL MANAGEMENT LLC | $11 261 911 | 882 595 | 8,30% | Acciones |
| VANGUARD GROUP INC | $10 521 710 | 673 605 | 7,76% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $8 828 580 | 691 895 | 6,51% | Acciones |
| Jones Hill Capital LP | $7 980 461 | 625 428 | 5,88% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $5 044 670 | 395 260 | 3,72% | Acciones |
| Ishara Investments LP | $4 316 070 | 338 250 | 3,18% | Acciones |
| STATE STREET CORP | $3 462 732 | 271 374 | 2,55% | Acciones |
| UBS Group AG | $2 956 262 | 231 682 | 2,18% | Acciones |
| CITADEL ADVISORS LLC | $2 499 161 | 195 859 | 1,84% | Acciones |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $2 107 237 | 165 144 | 1,55% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 864 236 | 146 100 | 1,37% | Opción de venta |
| JANE STREET GROUP, LLC | $1 778 744 | 139 400 | 1,31% | Opción de venta |
| Balyasny Asset Management L.P. | $1 691 861 | 132 591 | 1,25% | Acciones |
| NORTHERN TRUST CORP | $1 536 126 | 120 386 | 1,13% | Acciones |
| Nuveen, LLC | $1 498 624 | 117 447 | 1,11% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $1 302 209 | 102 054 | 0,96% | Acciones |
| GOLDMAN SACHS GROUP INC | $1 255 023 | 98 356 | 0,93% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 249 893 | 97 954 | 0,92% | Acciones |
| FMR LLC | $1 193 714 | 93 551 | 0,88% | Acciones |
| IEQ CAPITAL, LLC | $1 178 679 | 92 373 | 0,87% | Acciones |
| Susquehanna Portfolio Strategies, LLC | $829 706 | 65 024 | 0,61% | Acciones |
| SUPERSTRING CAPITAL MANAGEMENT LP | $812 148 | 63 648 | 0,60% | Acciones |
| Trexquant Investment LP | $811 983 | 63 635 | 0,60% | Acciones |
| BANK OF AMERICA CORP /DE/ | $778 067 | 60 977 | 0,57% | Acciones |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $739 353 | 57 943 | 0,55% | Acciones |
| PANAGORA ASSET MANAGEMENT INC | $723 569 | 56 706 | 0,53% | Acciones |
| Legato Capital Management LLC | $709 711 | 55 620 | 0,52% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $671 342 | 52 613 | 0,50% | Acciones |
| CITADEL ADVISORS LLC | $586 960 | 46 000 | 0,43% | Opción de compra |
| CITADEL ADVISORS LLC | $576 752 | 45 200 | 0,43% | Opción de venta |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $549 114 | 43 034 | 0,40% | Acciones |
| Mariner, LLC | $532 983 | 41 770 | 0,39% | Acciones |
| Bank of New York Mellon Corp | $532 784 | 41 754 | 0,39% | Acciones |
| Quarry LP | $526 350 | 41 250 | 0,39% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $520 608 | 40 800 | 0,38% | Opción de compra |
| JANE STREET GROUP, LLC | $514 228 | 40 300 | 0,38% | Opción de compra |
| Invesco Ltd. | $480 937 | 37 691 | 0,35% | Acciones |
| SEI INVESTMENTS CO | $465 383 | 36 472 | 0,34% | Acciones |
| Cerity Partners LLC | $396 506 | 31 074 | 0,29% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $367 641 | 28 812 | 0,27% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $330 413 | 24 030 | 0,24% | Acciones |
| MERCER GLOBAL ADVISORS INC /ADV | $303 918 | 23 818 | 0,22% | Acciones |
| GREAT LAKES ADVISORS, LLC | $303 076 | 23 752 | 0,22% | Acciones |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $296 698 | 23 679 | 0,22% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $255 200 | 20 000 | 0,19% | Acciones |
| Man Group plc | $238 216 | 18 669 | 0,18% | Acciones |
| RHUMBLINE ADVISERS | $222 448 | 17 434 | 0,16% | Acciones |
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Seth Lederman, Lederman & Co., LLC, L&L Technologies, LLC, Targent Pharmaceuticals, LLC, Leder Laboratories, Inc., Starling Pharmaceuticals, Inc. ×3 presentaciones | 10 de febrero de 2015 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 25 insiders · 9 directivos · 14 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Seth Lederman | Chief Executive Officer | 27 de agosto de 2026 P | 11 005 | 4 | 0 | $372 980 |
| David J Moss | PRES, CEO, TRES, CFO, SECR | 5 de mayo de 2011 P | 3 250 000 | 0 | 0 | $0 |
| Bradley Saenger | Chief Financial Officer | 30 de junio de 2026 J | 2 154 | 0 | 0 | $0 |
| Leland Gershell | Chief Financial Officer | 28 de septiembre de 2015 P | 19 260 | 0 | 0 | $0 |
| Jessica Edgar Morris | Chief Operating Officer | 24 de febrero de 2026 A | 0 | 0 | 0 | $0 |
| Siobhan Fogarty | Chief Technology Officer | 24 de febrero de 2026 A | · | 0 | 0 | $0 |
| Gregory M Sullivan | Chief Medical Officer | 24 de febrero de 2026 A | 0 | 0 | 0 | $0 |
| Bruce Daugherty | Chief Scientific Officer and Secretary | 21 de junio de 2016 P | 100 000 | 0 | 0 | $0 |
| Donald J Kellerman | Senior Vice President, Clinical Development and Medical Affairs | 29 de octubre de 2014 A | · | 0 | 0 | $0 |
| Richard H Bagger | Consejero | 20 de agosto de 2026 P | 1 000 | 1 | 0 | $12 600 |
| Carolyn E. Taylor | Consejero | 12 de junio de 2026 P | 1 833 | 1 | 0 | $14 928 |
| Richard Newcomb Stillwell | Consejero | 8 de junio de 2026 P | 5 000 | 1 | 0 | $58 250 |
| James Randolph Hunter Jr | Consejero | 12 de mayo de 2026 A | · | 0 | 0 | $0 |
| James Treco | Consejero | 12 de mayo de 2026 A | 250 | 0 | 0 | $0 |
| Margaret Smith Bell | Consejero | 12 de mayo de 2026 A | 0 | 0 | 0 | $0 |
| David L Grange | Consejero | 12 de mayo de 2026 A | · | 0 | 0 | $0 |
| Adeoye Y Olukotun | Consejero | 12 de mayo de 2026 A | 0 | 0 | 0 | $0 |
| Ernest Mario | Consejero | 25 de junio de 2018 P | 50 000 | 0 | 0 | $0 |
| Charles E Mather IV | Consejero | 12 de junio de 2018 A | 1 783 | 0 | 0 | $0 |
| Samuel R Saks | Consejero | 12 de junio de 2018 A | 3 855 | 0 | 0 | $0 |
| Stuart Davidson | Consejero | 20 de junio de 2017 A | 1 490 716 | 0 | 0 | $0 |
| Daniel Wintner Goodman | · | 25 de mayo de 2021 P | 5 001 | 0 | 0 | $0 |
| John B Rhodes | · | 4 de mayo de 2020 A | 23 470 | 0 | 0 | $0 |
| Donald W Landry | · | 6 de mayo de 2019 A | 7 710 | 0 | 0 | $0 |
| Patrick P Grace | · | 6 de mayo de 2019 A | 1 255 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 13 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,34% | 8 456 SH | 2 de octubre de 2026 | Diario |
| IBRN · iShares Trust | 0,21% | 1 270 SH | 11 de septiembre de 2026 | Diario |
| IWC · iShares Trust | 0,04% | 49 940 SH | 11 de septiembre de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 35 620 SH | 2 de octubre de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 83 757 SH | 19 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 12 927 SH | 19 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,01% | 382 760 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,00% | 6 926 NS | 31 de julio de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 4 993 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 187 414 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 488 108 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1 270 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | · | 144 932 SH | 11 de septiembre de 2026 | Diario |
TNXP Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 10 analistas
COMPRA
Objetivo mediano
$45.50
+410,7%
3 30,0%
Compra fuerte
6 60,0%
Compra
1 10,0%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
4 analistas · 2026-09-28Objetivo medio $44.50 +399,4%
← Por Debajo de Todos los Objetivos
Precio Actual $8.91
Mín$22.00
Media$44.50
Máx$65.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| TNXP | $200M | -1.1 | 29.8% | -946.2% | -60.0% | · |
| TARA | $286M | -4.0 | · | · | -33.7% | · |
| PEPG | $448M | -3.1 | · | · | -82.0% | · |
| NERV | $174M | -0.1 | · | · | 339.5% | · |
| NBP | $1.06B | -19.0 | · | · | -21.4% | · |
| CMPX | $958M | · | · | · | -45.9% | · |
| ABOS | $128M | -1.1 | · | · | -129.4% | · |
| HUMA | · | · | · | · | · | · |
| OTLK | $57M | -0.6 | · | -4416.2% | 193.1% | 4.0% |
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | · |
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 10, 2026